PayPal Holdings, Inc. (BMV:PYPL)

Revance Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6,688	6,561	9,081	7,776	5,197	4,794
Short-Term Investments	3,320	4,262	4,979	3,092	4,303	8,289
Cash & Short-Term Investments	10,008	10,823	14,060	10,868	9,500	13,083
Cash Growth	-26.50%	-23.02%	29.37%	14.40%	-27.39%	21.58%
Accounts Receivable	1,099	984	1,069	963	800	577
Other Receivables	117	140	101	65	36	42
Receivables	8,154	7,546	6,603	8,459	5,682	3,388
Prepaid Expenses	1,593	1,375	1,023	976	963	724
Restricted Cash	-	-	-	-	5	340
Other Current Assets	39,307	40,807	40,320	37,121	36,424	33,460
Total Current Assets	59,879	61,092	62,569	57,424	52,574	50,995
Property, Plant & Equipment	1,625	2,180	1,878	2,304	2,568	2,514
Long-Term Investments	3,645	4,583	3,273	5,018	6,797	6,082
Goodwill	10,976	10,837	11,026	11,209	11,454	9,135
Other Intangible Assets	271	326	537	788	1,332	1,048
Long-Term Accounts Receivable	-	207	185	-	-	-
Long-Term Deferred Tax Assets	-	-	-	-	547	142
Other Long-Term Assets	3,381	2,386	2,698	1,881	531	463
Total Assets	79,777	81,611	82,166	78,624	75,803	70,379
Accounts Payable	221	227	139	126	197	252
Accrued Expenses	3,089	6,862	3,198	3,261	2,154	1,984
Short-Term Debt	-	-	359	-	-	-
Current Portion of Long-Term Debt	159	1,191	1,249	418	999	-
Current Portion of Leases	141	140	144	151	142	144
Current Income Taxes Payable	-	-	-	-	236	129
Other Current Liabilities	41,440	39,956	43,377	41,052	39,301	35,938
Total Current Liabilities	45,050	48,376	48,466	45,008	43,029	38,447
Long-Term Debt	11,296	9,879	9,676	10,417	8,049	8,939
Long-Term Leases	576	647	416	569	620	642
Long-Term Deferred Tax Liabilities	-	-	-	-	186	75
Other Long-Term Liabilities	2,654	2,292	2,557	2,356	2,192	2,213
Total Liabilities	59,576	61,194	61,115	58,350	54,076	50,316
Additional Paid-In Capital	21,136	20,705	19,642	18,327	17,208	16,644
Retained Earnings	29,915	27,347	23,200	18,954	16,535	12,366
Treasury Stock	-30,111	-27,085	-21,045	-16,079	-11,880	-8,507
Comprehensive Income & Other	-739	-550	-746	-928	-136	-484
Total Common Equity	20,201	20,417	21,051	20,274	21,727	20,019
Minority Interest	-	-	-	-	-	44
Shareholders' Equity	20,201	20,417	21,051	20,274	21,727	20,063
Total Liabilities & Equity	79,777	81,611	82,166	78,624	75,803	70,379
Total Debt	12,172	11,857	11,844	11,555	9,810	9,725
Net Cash (Debt)	-2,164	-1,034	2,216	-687	-310	3,358
Net Cash Growth	-	-	-	-	-	-36.51%
Net Cash Per Share	-2.16	-1.00	2.00	-0.59	-0.26	2.83
Filing Date Shares Outstanding	955.38	989.24	1,072	1,131	1,165	1,171
Total Common Shares Outstanding	960	993	1,072	1,136	1,168	1,172
Working Capital	14,829	12,716	14,103	12,416	9,545	12,548
Book Value Per Share	21.04	20.56	19.64	17.85	18.60	17.08
Tangible Book Value	8,954	9,254	9,488	8,277	8,941	9,836
Tangible Book Value Per Share	9.33	9.32	8.85	7.29	7.65	8.39
Land	-	337	333	388	380	340
Machinery	-	3,493	3,495	3,521	3,444	3,378
Construction In Progress	-	104	34	25	86	83
Leasehold Improvements	-	343	317	364	379	377

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.